Publications by authors named "Juergen Burhenne"

16Publications

Minor contribution of cytochrome P450 3A activity on fentanyl exposure in palliative care cancer patients.

Sci Rep 2019 10 10;9(1):14635. Epub 2019 Oct 10.

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-51279-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786992PMC
October 2019

Alteration of drug-metabolizing enzyme activity in palliative care patients: Microdosed assessment of cytochrome P450 3A.

Palliat Med 2019 07 26;33(7):850-855. Epub 2019 Apr 26.

2 Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269216319843629DOI Listing
July 2019

Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapies.

Basic Clin Pharmacol Toxicol 2019 Aug 15;125(2):117-122. Epub 2019 Apr 15.

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcpt.13232DOI Listing
August 2019

Obesity-induced CYP2E1 activity in children.

Br J Clin Pharmacol 2019 02 9;85(2):458-459. Epub 2018 Dec 9.

Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.13813DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339961PMC
February 2019

Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin.

Eur J Clin Pharmacol 2018 Nov 12;74(11):1405-1415. Epub 2018 Jul 12.

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital-Huddinge, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-018-2499-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182598PMC
November 2018

Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor Growth.

Ann Surg 2017 04;265(4):782-791

*Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany †Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001696DOI Listing
April 2017

Systemic exposure of topical erythromycin in comparison to oral administration and the effect on cytochrome P450 3A4 activity.

Br J Clin Pharmacol 2014 Dec;78(6):1433-40

Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12497DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256632PMC
December 2014

Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers.

Br J Clin Pharmacol 2014 Jan;77(1):141-8

Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895355PMC
January 2014

Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.

Circ Heart Fail 2011 Mar 7;4(2):198-206. Epub 2011 Jan 7.

Keenan Research Centre at the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.110.957050DOI Listing
March 2011

High absolute bioavailability of methylene blue given as an aqueous oral formulation.

Eur J Clin Pharmacol 2009 Feb 23;65(2):179-89. Epub 2008 Sep 23.

Department of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology, University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-008-0563-xDOI Listing
February 2009

Influence of lipid lowering fibrates on P-glycoprotein activity in vitro.

Biochem Pharmacol 2004 Jan;67(2):285-92

Department of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Bergheimer Strasse 58, D-69115, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2003.09.008DOI Listing
January 2004